• 1. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 5. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090

Comprehensive Overview of Lithium(1+) 4-cyanopyrimidine-2-carboxylate (CAS No. 2703774-95-0): Properties, Applications, and Industry Relevance

Lithium(1+) 4-cyanopyrimidine-2-carboxylate (CAS No. 2703774-95-0) is a specialized organic lithium salt gaining attention in pharmaceutical and materials science research. This compound, characterized by its unique pyrimidine backbone and cyano functional group, exhibits properties that make it valuable for advanced applications. The molecular structure combines a carboxylate moiety with a lithium counterion, offering distinct solubility and reactivity profiles compared to conventional pyrimidine derivatives.

In recent years, the demand for high-performance lithium-based compounds has surged, driven by innovations in battery technology and drug development. Researchers are particularly interested in how 4-cyanopyrimidine-2-carboxylate derivatives can contribute to next-generation electrolyte formulations or serve as intermediates in small-molecule drug synthesis. The compound's thermal stability and ionic conductivity are under investigation for potential use in energy storage systems, aligning with global trends toward sustainable energy solutions.

The synthesis of Lithium(1+) 4-cyanopyrimidine-2-carboxylate typically involves the lithiation of 4-cyanopyrimidine-2-carboxylic acid, followed by purification processes to achieve high purity grades (>98%). Analytical techniques like HPLC, NMR spectroscopy, and mass spectrometry are employed to verify its structural integrity. Its crystalline form shows promising shelf-life characteristics, making it suitable for long-term storage in research laboratories.

From a pharmaceutical perspective, this compound's pyrimidine core is structurally analogous to nucleobases, sparking interest in its potential as a building block for antiviral or anticancer agents. Recent publications have explored its role in modulating enzyme inhibition pathways, particularly in kinase-targeted therapies. However, comprehensive clinical studies are still needed to validate these preliminary findings.

In material science, the lithium-cyanopyrimidine complex demonstrates intriguing coordination chemistry properties. Its ability to form stable complexes with transition metals is being examined for applications in organic electronics and catalysis. The compound's electron-withdrawing cyano group enhances its utility in designing π-conjugated systems for optoelectronic devices.

Quality control standards for CAS 2703774-95-0 require strict monitoring of residual solvents and heavy metal content. Reputable suppliers provide detailed certificates of analysis (CoA) and material safety data sheets (MSDS), though it's crucial to note this compound is not classified as hazardous under standard handling conditions. Proper storage in anhydrous environments at controlled temperatures is recommended to maintain stability.

The market for specialty lithium compounds like this is projected to grow significantly, with increasing R&D investments in personalized medicine and green energy technologies. Patent analyses reveal growing intellectual property activity around modified pyrimidine derivatives, suggesting expanding commercial applications. Current pricing reflects its status as a research-grade chemical, with costs varying based on purity levels and order quantities.

For researchers considering Lithium(4-cyanopyrimidine-2-carboxylate) in their work, compatibility studies with common organic solvents (DMF, DMSO, acetonitrile) show excellent results. Its solubility profile makes it particularly suitable for homogeneous catalysis systems. Recent advancements in flow chemistry techniques have enabled more efficient large-scale processing of such sensitive organolithium compounds.

Environmental impact assessments indicate that 2703774-95-0 demonstrates favorable biodegradation potential compared to persistent organic pollutants. However, standard laboratory waste management protocols should be followed. The scientific community continues to explore green chemistry approaches to optimize its synthesis and minimize byproduct formation.

Emerging studies suggest potential synergies between this compound and biomaterial engineering, particularly in developing drug delivery matrices. Its anionic carboxylate group allows for interesting ionic interactions with polymeric carriers. These developments align with current trends in targeted therapy and controlled release systems that dominate pharmaceutical research discussions.

In analytical applications, 4-cyanopyrimidine-2-carboxylate lithium salt serves as a valuable reference standard for method development in LC-MS systems. Its distinct UV absorption characteristics facilitate detection at low concentrations. This utility is particularly relevant given the increasing regulatory emphasis on impurity profiling in active pharmaceutical ingredients.

Future research directions for CAS 2703774-95-0 may explore its electrochemical behavior in solid-state battery configurations or investigate its supramolecular assembly properties. The compound's versatility across multiple scientific disciplines positions it as an interesting candidate for interdisciplinary innovation at the chemistry-biology-materials science interface.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)